Skip to main content

Darbepoetin Alfa News

FDA Medwatch Alert: Erythropoiesis-Stimulating Agents (ESAs) In Chronic Kidney Disease: Drug Safety Communication - Modified Dosing Recommendations

Epoetin alfa (marketed as Epogen and Procrit) and darbepoetin alfa (marketed as Aranesp) ISSUE: FDA notified healthcare professionals that new, modified recommendations for more conservative dosing...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Darbepoetin Alfa patient information at Drugs.com